Gliclazide (60mg) MR + Pioglitazone (15mg) + Metformin (500mg) SR is a combination medication used to treat type 2 diabetes. It combines three different drugs, each with a distinct mechanism of action, to help control blood sugar levels. Gliclazide stimulates the pancreas to release more insulin, pioglitazone enhances insulin sensitivity, and metformin reduces glucose production in the liver and improves insulin sensitivity in muscles
